| http://www.w3.org/ns/prov#value | - itors and methods of their useUS6610682Aug 21, 2001Aug 26, 2003Sankyo Company, LimitedComprising insulin resistance improving agents in combination with drugs selected from angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors with a diluent or carrierUS6730687 *Aug 18, 2000May 4, 2004Kyorin Pharmaceutical Co., Ltd.Therapy of metabolic diseases such as diabetes and hyper
|
